The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents

第22届卡波西肉瘤相关疱疹病毒及相关药物国际会议

• 批准号: 9763269
• 负责人: ETHEL CESARMAN
• 金额: $ 0.8万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-09 至 2020-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763269
• 关键词: Academia; Acquired Immunodeficiency Syndrome; Anniversary; Applications Grants; Asia; Biology; Biotechnology; Cancer Etiology; Career Mobility; Cessation of life; Clinical; Collaborations; Country; DNA Viruses; Data; Development; Discipline; Disease; Educational workshop; Epidemiology; Europe; Fees; Foundations; Funding; Funding Mechanisms; Gene Expression; Goals; Government; HIV; Herpesviridae; Hour; Human; Human Herpesvirus 4; Human Herpesvirus 8; Immune response; Industry; Infection; Institution; International; Kaposi Sarcoma; Knowledge; Lymphocryptovirus; Macaca mulatta; Malignant Neoplasms; Mentors; Mission; Murine herpesvirus 68; Mus; National Institute of Allergy and Infectious Disease; National Institute of Dental and Craniofacial Research; New York City; North America; Oncogenic; Oral; Pathogenesis; Pharmacologic Substance; Postdoctoral Fellow; Prevention strategy; Request for Applications; Research; Research Personnel; Research Priority; Rhadinovirus; Saimiriine Herpesvirus 2; Site; Therapeutic Intervention; Time; Underrepresented Minority; United States National Institutes of Health; Update; Viral; Viral Genes; Viral Pathogenesis; Virus; Virus Latency; cost; expectation; gammaherpesvirus; human DNA; human disease; meetings; minority scientist; pathogen; posters; pre-doctoral; research and development; symposium; treatment strategy; vaccination strategy; vaccine development

ABSTRACT This conference grant application requests funds to help support the 22nd International Conference on Kaposi's Sarcoma Herpesvirus and Related Agents in 2019. Our annual conference will bring together researchers and clinicians working on the oncogenic human herpesvirus, Kaposi's sarcoma herpesvirus (KSHV), and other closely related pathogens. The funds will be used to reduce the conference registration costs for outstanding US pre- and post- doctoral trainees, historically under-represented minorities, and scientists from poor countries who study oncogenic DNA viruses. The goals of these meetings are consistent with the mission statements of the NIH, NCI, NIAID, and NIDCR, namely, to advance and promote the pace of research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The KSHV conference will be held in New York City and will occur from the evening of June 30 through the morning of July 3, 2019. All remaining costs for these conferences will be raised from registration fees paid by the conferees and contributions from host institutions, foundations, and pharmaceutical and biotechnology companies. The main focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, and therapeutic intervention. In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. The 22nd International Conference on Kaposi's Sarcoma-Associated Herpesvirus and Related Agents is the 25th anniversary of the virus's discovery. ! !

摘要 本次会议赠款申请要求资金，以帮助支持第22届国际 2019年卡波西肉瘤疱疹病毒和相关药物会议。我们的年度 会议将汇集研究致癌人类的研究人员和临床医生， 疱疹病毒、卡波西肉瘤疱疹病毒（KSHV）和其它密切相关的病原体。的 资金将用于降低美国会议前和会议后的会议注册费用， 博士生，历史上代表性不足的少数民族，以及来自贫穷国家的科学家 他们研究致癌DNA病毒。这些会议的目标与使命一致 国家卫生研究院，NCI，NIAID和NIDCR的声明，即推进和促进的步伐， 研究与人类癌症和其他疾病有关的感染，包括 艾滋病的背景。KSHV会议将在纽约市举行， 2019年6月30日晚至7月3日上午。所有剩余费用 会议的经费将从与会者支付的注册费和 主办机构、基金会以及制药和生物技术公司。主要 KSHV会议的重点是致癌疱疹病毒和相关人类的生物学， 疾病，特别强调病毒发病机制，病毒潜伏期和再激活，病毒基因 表达和复制，宿主对感染的反应，流行病学，疫苗开发， 和治疗干预。除了KSHV，与松鼠猴疱疹病毒（HVS）相关的研究， 鼠疱疹病毒-68（MHV-68）和恒河猴鼻状病毒（RRV）。第22 卡波济肉瘤相关疱疹病毒及相关因子国际会议 病毒发现25周年纪念日 ! !